Biotech VCs Turn to Public Investments in Search of Value
Tom Rose, a partner with Troutman Pepper, was quoted in the February 1, 2024 Wall Street Journal article, " Biotech VCs Turn to Public Investments in Search of Value."
Companies negotiate PIPEs privately with investors and only announce them after reaching a deal. PIPE investors can't trade their shares until material nonpublic information they have seen is revealed publicly, said Thomas Rose, a partner with law firm Troutman Pepper Hamilton Sanders.